News for Providers
Top stories summarized by our editors
9/17/2018

Animals and environmental elements are holistic and practical resources that should be part of interaction with clients, an associate professor of social work at Trinity Christian College in Illinois asserts. Applications could range from understanding pet loss to counseling refugees displaced by climate change, Cini Bretzlaff-Holstein noted.

9/17/2018

About 65% of health care executives have changed their definition of patient-centered care to include providing educational resources and access to coordinated care, according to a survey by Modern Healthcare. More than 94% of executives surveyed said they are investing in technology to provide better care.

9/17/2018

Patients with psoriasis and psoriatic arthritis were at a 40% and 50% increased risk of developing type 2 diabetes, respectively, compared with the general population, according to a study in Rheumatology. Researchers found that PsA patients also had a 40% increased risk for peripheral vascular disease, a 29% increased risk for combined cardiovascular diseases and a 27% increased risk for ischemic heart disease, compared with the general population.

More Summaries:
psoriatic arthritis, Psoriasis
9/17/2018

Researchers analyzed data on 6,450 patients with diabetes from the ACCORD BP trial and the National Health and Nutrition Examination Survey and found those in the intensive blood pressure treatment group had 14.4 total cardiovascular events per 1,000 person-years from the weighted sample, compared with 20.2 in the standard treatment group, which was different from the unweighted sample at 18.98 in the intensive BP treatment group and 21.27 in the standard treatment group. The findings in the Journal of the American College of Cardiology revealed no difference in total mortality and microvascular event risk between the two groups.

Full Story:
Endocrinology Advisor
More Summaries:
BP
9/17/2018

A 77,115-patient cohort study in Diabetes Care showed that patients with type 2 diabetes who took GLP-1 receptor agonists were at a 33% reduced risk for diabetic retinopathy, compared with new insulin users. However, researchers found that taking GLP-1 receptor agonists between 6.1 months and 12 months was tied to a 44% increased diabetic retinopathy risk.

Full Story:
Endocrinology Advisor
9/17/2018

Researchers found that Latino adults who experienced routine discrimination had an increased waist circumference and showed signs of depression, but there was a nonsignificant association between body mass index and discrimination. The findings in Obesity, based on 602 adults ages 21 to 85 from the Latino Health and Well-being Project, revealed a positive association between depressive symptoms and BMI, but not waist circumference, and a positive correlation between BMI and waist circumference.

More Summaries:
Obesity
9/17/2018

Persistent sleep-disordered breathing was almost four times more likely among obese children, compared with those who were not obese, researchers reported in Pediatric Obesity. Weight loss increased the likelihood that symptoms of sleep-disordered breathing would go into remission, the study found.

More Summaries:
Obesity
9/17/2018

A panel at a provider symposium at Health 2.0 focused on a fundamental issue to solve before health care data can be used to transform patient care: the building of trust among the stakeholders in the health care system. A lack of trust leads to data asymmetry among providers, payers and patients and the inability to unlock the potential innovation.

Full Story:
MedCity News
9/17/2018

Figures from the HHS' National Survey on Drug Use and Health showed the number of people who misused or were addicted to opioid painkillers dropped to 11.4 million last year from 11.8 million in 2016 and 12.7 million in 2015. Hydrocodone and oxycodone were the most commonly abused opioid drugs, and most opioid users got their drugs free from friends or relatives, but 34.6% got them from a physician, the survey found.

More Summaries:
HHS, hydrocodone, painkillers, oxycodone
9/17/2018

FDA Commissioner Scott Gottlieb called for new funding mechanisms to support the battle against antimicrobial resistance, while also disclosing the agency's 2019 strategic plan that focuses on AMR. Gottlieb spoke of four crucial areas to address, including the development of products and surveillance tools for antimicrobial use and resistance, promotion of antimicrobial stewardship and support for research initiatives to discover alternative treatment approaches.

Full Story:
BioCentury
More Summaries:
Commissioner Scott Gottlieb, FDA